Skip to content

Clinical trials

Completed Phase 3 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 3 Status: Completed Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20041
20051
20064
20071
20081
20102
20112
20132
20141
20152
20164
20172
20181
20191
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)4
Assistance Publique - Hôpitaux de Paris3
Mast Therapeutics, Inc.3
Indiana University2
Pfizer2
Vanderbilt University Medical Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Augusta University1
Biossil Inc.1
Children's Healthcare of Atlanta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell35
Hematologic Diseases7
Vaso-Occlusive Crises5
Pain4
Stroke4
Hemoglobinopathies3
Malaria3
Agnosia2
Anemia2
Rare Diseases2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.